Persistent hyperkalemia in a patient with diabetes mellitus: a reversible defect in kaliuresis during bicarbonaturia.
The purpose of this report is to apply recent advances in the understanding of the physiology of the excretion of potassium to a patient who had hyperkalemia due to a low rate of excretion of potassium. The defect was first suspected during therapy for diabetic ketoacidosis, when the concentration of potassium in plasma was unusually high (7.3 mmol/l) on admission and the deficit of potassium, as judged from the quantity of potassium infused to maintain normokalemia (40 mmol/24 h), was much less than expected. After recovery from diabetic ketoacidosis, hyperkalemia persisted despite near-normal values for creatinine and glucose in plasma. Excretion of potassium was low, considering the stimulus of hyperkalemia, and did not rise appreciably after the acute or chronic administration of a mineralocorticoid. The transtubular potassium concentration gradient (TTKG) did not exceed 6 after a large dose of fludrocortisone (200 micrograms) was administered. Notwithstanding, the TTKG rose to 14.4 following the intake of acetazolamide. We speculate that the basis for the hyperkalemia was type II hypoaldosteronism.
Kaiser
U B
UB
Renal Division, St. Michael's Hospital, Toronto, Ontario.
Ethier
J H
JH
Kamel
K S
KS
Halperin
M L
ML
D001639:Bicarbonates / Q000652:urine*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000652:urine; D016883:Diabetic Ketoacidosis / Q000150:complications; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine*
D001639:Bicarbonates; D011188:Potassium